Selective cyclooxygenase-2 inhibitors: similarities and differencesBRUNE, K; HINZ, B.Scandinavian journal of rheumatology. 2004, Vol 33, Num 1, pp 1-6, issn 0300-9742, 6 p.Article

Faut-il un éditorial de plus sur les coxibs ? = Is a further editorial on coxibs required?BERGMANN, J.-F; CHAMPION, K; MOULY, S et al.La Presse médicale (1983). 2005, Vol 34, Num 10, pp 699-700, issn 0755-4982, 2 p.Article

COX-2-Hemmer und kardiovaskuläre Ereignisse = COX-2 inhibitors and cardiovascular eventsKÖTTER, I.Zeitschrift für Rheumatologie (Print). 2007, Vol 66, Num 3, issn 0340-1855, 243-246 [3 p.]Article

Selective cyclooxygenase 2 inhibitors and cardiovascular eventsSOLOMON, Daniel H.Arthritis and rheumatism. 2005, Vol 52, Num 7, pp 1968-1978, issn 0004-3591, 11 p.Article

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?MASCLEE, G. M. C; VALKHOFF, V. E; STURKENBOOM, M. C. J. M et al.Alimentary pharmacology & therapeutics. 2013, Vol 38, Num 2, pp 178-189, issn 0269-2813, 12 p.Article

2,4,5-TMBA, a Natural Inhibitor of Cyclooxygenase-2, Suppresses Adipogenesis and Promotes Lipolysis in 3T3-L1 AdipocytesWU, Man-Ru; HOU, Ming-Hon; LIN, Ya-Lin et al.Journal of agricultural and food chemistry (Print). 2012, Vol 60, Num 29, pp 7242-7249, issn 0021-8561, 8 p.Article

A Novel COX-2 Inhibitor Pyrazole Derivative Proven Effective as an Anti-Inflammatory and Analgesic DrugMOHY EL-DIN, Mahmoud M; SENBEL, Amira M; BISTAWROOS, Azza A et al.Basic & clinical pharmacology & toxicology (Print). 2011, Vol 108, Num 4, pp 263-273, issn 1742-7835, 11 p.Article

Ocular adverse effects associated with cyclooxygenase-2 inhibitorsFRAUNFELDER, Frederick W; SOLOMON, Jonathan; MEHELAS, Thomas J et al.Archives of ophthalmology (1960). 2006, Vol 124, Num 2, pp 277-279, issn 0003-9950, 3 p.Article

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitorsFISCHER, Michael A; SCHNEEWEISS, Sebastian; AVORN, Jerry et al.The New England journal of medicine. 2004, Vol 351, Num 21, pp 2187-2194, issn 0028-4793, 8 p.Article

Potential role of the new specific COX-2 inhibitors in dermatologic surgery. CommentaryWEISBERG, N. K; BECKER, D; OTLEY, C. C et al.Dermatologic surgery. 2000, Vol 26, Num 6, pp 551-553, issn 1076-0512Article

Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugsCORZO, J. L; ZAMBONINO, M. A; MUNOZ, C et al.British journal of dermatology (1951). 2014, Vol 170, Num 3, pp 725-729, issn 0007-0963, 5 p.Article

Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitorsGIERSE, James; NICKOLS, Maureen; LEAHY, Kathleen et al.European journal of pharmacology. 2008, Vol 588, Num 1, pp 93-98, issn 0014-2999, 6 p.Article

Production of a COX-2 inhibitor, 2,4,5-trimethoxybenzaldehyde, with submerged cultured Antrodia camphorataCHEN, C.-C; CHYAU, C.-C; HSEU, T.-H et al.Letters in applied microbiology. 2007, Vol 44, Num 4, pp 387-392, issn 0266-8254, 6 p.Article

Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritisBAUER, Andrea M; FIEHN, Christoph; BECKER, Matthias D et al.American journal of ophthalmology. 2005, Vol 139, Num 6, pp 1086-1089, issn 0002-9394, 4 p.Article

Determinants of selective cyclooxygenase-2 inhibitor prescribing: Are patient or physician characteristics more important?SOLOMON, Daniel H; SCHNEEWEISS, Sebastian; GLYNN, Robert J et al.The American journal of medicine. 2003, Vol 115, Num 9, pp 715-720, issn 0002-9343, 6 p.Article

The pre-emptive analgesic effect of a cyclooxygenase-2 inhibitor in a rat model of acute postoperative painCHEN, J. J; HUNG, K. C; LU, K et al.Anaesthesia. 2012, Vol 67, Num 11, pp 1225-1231, issn 0003-2409, 7 p.Article

Luteinized Unruptured Follicle Syndrome Increased by Inactive Disease and Selective Cyclooxygenase 2 Inhibitors in Women With Inflammatory ArthropathiesMICU, MihaelaC; MICU, Romeo; OSTENSEN, Monika et al.Arthritis care and research. 2011, Vol 63, Num 9, pp 1334-1338, issn 0893-7524, 5 p.Article

Experimental studies of fracture healing, tendon healing and tendon-to-bone healing in the ratDIMMEN, Sigbjørn; MADSEN, Jan Erik.Acta orthopaedica. Supplementum (Print). 2011, Vol 82, Num 342, issn 1745-3690, 24 p.Thesis

RNAi-Based Strategies for Cyclooxygenase-2 Inhibition in CancerSTRILLACCI, Antonio; GRIFFONI, Cristiana; CHIARA VALERII, Maria et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 828045.1-828045.11, 2Article

Delayed progression of pancreatic intraepithelial neoplasia in a conditional kras^G12D mouse model by a selective cyclooxygenase-2 inhibitorFUNAHASHI, Hitoshi; SATAKE, Makoto; DAWSON, David et al.Cancer research (Baltimore). 2007, Vol 67, Num 15, pp 7068-7071, issn 0008-5472, 4 p.Article

Potent inhibition of in vivo angiogenesis and tumor growth by a novel cyclooxygenase-2 inhibitor, enoic acanthoic acidHYE JIN JUNG; JOONG SUP SHIM; SUH, Young-Ger et al.Cancer science. 2007, Vol 98, Num 12, pp 1943-1948, issn 1347-9032, 6 p.Article

Y a-t-il des différences de tolérance cardiovasculaire entre AINS classiques et coxibs ? = Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?VALAT, Jean-Pierre; DERAY, Gilbert; HELOIRE, Francois et al.La Presse médicale. Hors-série. 2006, Vol 35, issn 1629-355X, 1S25-1S34Article

Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitorEIBL, Guido; TAKATA, Yasunori; BOROS, Laszlo G et al.Cancer research (Baltimore). 2005, Vol 65, Num 3, pp 982-990, issn 0008-5472, 9 p.Article

Mise au point sur la sécurité d'emploi des coxibs (inhibiteurs sélectifs de la cyclo-oxygénase 2) : Discussion clinique = Coxibs safetyConcours médical (Paris). 2004, Vol 126, Num 25, pp 1458-1460, issn 0010-5309, 3 p.Article

Le médicament du mois valdécoxib (Bextra®) = Valdecokib (Bextra®)SCHEEN, A. J; MALAISE, M.RMLG. Revue médicale de Liège. 2004, Vol 59, Num 4, pp 251-254, issn 0370-629X, 4 p.Article